Evidence map›Paper›PMID 27036398›Full record

ArticleBMC cancer2016

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.

Cecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, Hugo Lagercrantz, Per Kogner, Thomas Ringstedt, Malin Wickström, John Inge Johnsen

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Stearoylation cycle regulates the cell surface distribution of the PCP protein Vangl2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Cecilia DybergChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital Q6:05, SE-171 76, Stockholm, Sweden. cecilia.dyberg@ki.se.
Panagiotis PapachristouNeonatal Research Unit, Department of Women's and Children's Health, Astrid Lindgren Children's hospital, Q2:07, Karolinska Institutet, SE-171 76, Stockholm, Sweden.
Bjørn Helge HaugDepartment of Pediatrics, University-Hospital of Northern-Norway (UNN), 9037, Tromsø, Norway.
Hugo LagercrantzNeonatal Research Unit, Department of Women's and Children's Health, Astrid Lindgren Children's hospital, Q2:07, Karolinska Institutet, SE-171 76, Stockholm, Sweden.
Per KognerChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital Q6:05, SE-171 76, Stockholm, Sweden.
Thomas RingstedtNeonatal Research Unit, Department of Women's and Children's Health, Astrid Lindgren Children's hospital, Q2:07, Karolinska Institutet, SE-171 76, Stockholm, Sweden.
Malin WickströmChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital Q6:05, SE-171 76, Stockholm, Sweden.
John Inge JohnsenChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital Q6:05, SE-171 76, Stockholm, Sweden.
Karolinska Institutet · SEPrimary Health Care · QAUniversity Hospital of North Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe non-canonical Wnt/Planar cell polarity (PCP) signaling pathway is a major player in cell migration during embryonal development and has recently been implicated in tumorigenesis.

methodsTransfections with cDNA plasmids or siRNA were used to increase and suppress Prickle1 and Vangl2 expression in neuroblastoma cells and in non-tumorigenic cells. Cell viability was measured by trypan blue exclusion and protein expression was determined with western blotting. Transcriptional activity was studied with luciferase reporter assay and mRNA expression with real-time RT-PCR. Immunofluorescence stainings were used to study the effects of Vangl2 overexpression in non-tumorigenic embryonic cells. Statistical significance was tested with t-test or one-way ANOVA.

resultsHere we show that high expression of the PCP core genes Prickle1 and Vangl2 is associated with low-risk neuroblastoma, suppression of neuroblastoma cell growth and decreased Wnt/β-catenin signaling. Inhibition of Rho-associated kinases (ROCKs) that are important in mediating non-canonical Wnt signaling resulted in increased expression of Prickle1 and inhibition of β-catenin activity in neuroblastoma cells. In contrast, overexpression of Vangl2 in MYC immortalized neural stem cells induced accumulation of active β-catenin and decreased the neural differentiation marker Tuj1. Similarly, genetically modified mice with forced overexpression of Vangl2 in nestin-positive cells showed decreased Tuj1 differentiation marker during embryonal development.

conclusionsOur experimental data demonstrate that high expression of Prickle1 and Vangl2 reduce the growth of neuroblastoma cells and indicate different roles of PCP proteins in tumorigenic cells compared to normal cells. These results suggest that the activity of the non-canonical Wnt/PCP signaling pathway is important for neuroblastoma development and that manipulation of the Wnt/PCP pathway provides a possible therapy for neuroblastoma.

Indexed as

Animalsbeta CateninCarcinogenesisCell MovementCell PolarityCell SurvivalGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMembrane ProteinsMiceNeuroblastomarho-Associated KinasesTumor Suppressor ProteinsWnt Signaling Pathwaybeta CateninIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMembrane ProteinsPRICKLE1 protein, humanrho-Associated KinasesTumor Suppressor ProteinsVANGL2 protein, humanNeuroblastomaPrickle1Vangl2Wnt/PCP pathway

Identifiers

PMID27036398
PMCPMC4818482
OpenAlexW2325073587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.